Skip to content

An Observational survey on Management of Allergic Rhinitis by Physicians and Patient.

Unmet needs in allergic rhinitis: International Survey on Management of Allergic Rhinitis by Physician and Patient - ISMAR 2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/01/011295
Enrollment
2367
Registered
2018-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Allergic Rhinitis Health Condition 2: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Sanofi India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or female, adults or children (>= 6 years) with a rhinitis diagnosed by a physician since at least one year. 2. Outpatient visiting their physician for whatever reason. 3. Informed Consent obtained prior to any study procedures.

Exclusion criteria

Exclusion criteria: 1. Current participation in any clinical trial 2. Inability to complete patientâ??s questionnaire

Design outcomes

Primary

MeasureTime frame
To explore rhinitis attitudes and treatment practices among separate groups of physicians and patients, with the goal of identifying barriers to optimal management and revealing limitations of currently available treatments.Timepoint: Visit 1

Secondary

MeasureTime frame
1. To identify country/local features that may determine some therapeutic decisions (e.g., type of center, medication availability/cost, laboratory tests, traditions, geographical constrainsâ?¦). 2. To estimate the impact of guidelines â??in real lifeâ?? management of rhinitis and the quality of physicianâ??patient communication 3. To enhance treatment compliance and outcomesTimepoint: Visit 1

Countries

Algeria, Egypt, India, Iran (Islamic Republic of), Kuwait, Pakistan, Qatar, Saudi Arabia, United Arab Emirates

Contacts

Public ContactDr Mohit Trivedi

Sanofi (India) Limited

Deepa.Chodankar@sanofi.com02230707800

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026